All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 180 of 206 pages ‹ First < 178 179 180 181 182 > Last ›
HSL5512
 Squires BP.
 Physicians and the pharmaceutical industry.
 
CMAJ 1993 Nov 15;149:(10):1391-2
 
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=8221422
HSL9318
 Rankin K.
 Drug wholesalers in "93: no margin for error 
 Drug Store News for Pharm 1993 Nov 15;3:15-16, 18-19, 22
 
HSL4697
 Fletcher AP.
 Prescriber profile and postmarketing surveillance.
 
Lancet 1993 Nov 6;342:(8880):1179
 
HSL5020
 Kimbel KH.
 Prescriber profile and postmarketing surveillance.
 
Lancet 1993 Nov 6;342:(8880):1178-9
 
HSL5028
 Leufkens HG, Urquhart J.
 Prescriber profile and postmarketing surveillance.
 
Lancet 1993 Nov 6;342:(8880):1178
 
HSL5525
 Wells F.
 Prescriber profile and postmarketing surveillance.
 
Lancet 1993 Nov 6;342:(8880):1178
 
HSL5708
 WHO ethical criteria for medicinal drug promotion
 1993 Nov 5
 
HSL5705
 Information overload—presentation materials
 1993 Nov
 
HSL5706
 MacDonald G.
 Aurorix® 1994 marketing plan
 1993 Nov
 
HSL9240
 Grove D.
 Major opportunity in major medical 
 ComputerTalk Pharm 1993 Nov-Dec;13:6-7
 
HSL9305
 Epstein LG.
 Communicating with pharmacy management companies 
 Med Interface 1993 Nov;6:52-54, 57
 
HSL9314
 Gibaldi M.
 Prescription drugs and health care reform.
 
Pharmacotherapy 1993 Nov-Dec;13:(6):583-9
 
HSL9334
 Goyan JE.
 Withdrawal of a drug from the market. What should the prescriber do?
 JAMA. 1993 Oct 27;270:(16):1976-7
 
http://www.ncbi.nlm.nih.gov/pubmed/8411557
HSL4695
 Finley R.
 Deceptive X-ray films in an advertisement.
 
N Engl J Med 1993 Oct 14;329:(16):1207
 
HSL5701
 Borow W.
 Medical television. Prescription for progress
 JAMA. 1993 Oct 6;270:(13):1601-2
 
HSL1869
 Forrest DM, Ruedy J.
 Proposed guidelines for housestaff interaction with pharmaceutical companies.
 Ann R Coll Physicians Surg Can 1993 Oct;26:(5):291-3
 
HSL5019
 Keim SM, Sanders AB, Witzke DB, Dyne P, Fulginiti JW.
 Beliefs and practices of emergency medicine faculty and residents regarding professional interactions with the biomedical industry.
 
Ann Emerg Med 1993 Oct;22:(10):1576-81
 
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WB0-4G82KSP-G&_coverDate=10%2F31%2F1993&_alid=409874800&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6696&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=c9e69f46e454e334bb60e2c0aeaf1787
HSL5250
 Reeder M, Dougherty J, White LJ.
 Pharmaceutical representatives and emergency medicine residents: a national survey.
 Ann Emerg Med 1993 Oct;22:(10):1593-6
 
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WB0-4G82KSP-M&_coverDate=10%2F31%2F1993&_alid=417430899&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6696&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=01124d5f2a89fef2b4262231c96031b6
HSL5699
 Re: the promotion of Septrin (co-trimoxazole)
 1993 Oct;
 
HSL5700
 Summary of outcomes for topics commenced February 1991 to May 1992
 MaLAM International News 1993 Oct
 
HSL5702
 Ingram R.
 Speaking out: Get ready for changes in advertising and promotion
 Medical Marketing & Media 1993 Oct
 
HSL5703
 Leisten V, Schmieder W, Wenzel J.
 Proof of effectiveness:  “pharma-ads”
 1993 Oct
 
HSL5704
 Van STAA.
 Myth and metronidazole in Manila:  the popularity of drugs among prescribers and dispensers in the treatment of diarrhoea
 INRUD News 1993 Oct
 
HSL9302
 Baichwal RS.
 New dimensions in drug discovery 
 Pharma Times 1993 Oct;25:15, 17, 19, 21
 
HSL9306
 How you subsidize the drug industry 
 Consum Rep 1993 Oct;670-674
 
HSL9307
 How to buy drugs for less 
 Consum Rep 1993 Oct;675-676
 
HSL9308
 Do we pay too much for prescriptions? 
 Consum Rep 1993 Oct;668-669
 
HSL9309
 Henkel J.
 User fees to fund faster reviews.
 
FDA Consum 1993 Oct;27:(8):19-21
 
HSL9330
 Turowski RC, Raskay-Bianco MM, Visconti JA.
 Prescription assistance programs: options for assisting the uninsured and underinsured.
 
Hosp Pharm 1993 Oct;28:(10):948,
 
HSL5246
 Paulshock BZ.
 Single-drug therapy for hypertension in men.
 
N Engl J Med 1993 Sep 30;329:(14):1044-5
 
HSL4686
 Dean M.
 Conflicts of interest in drug regulation.
 
Lancet 1993 Sep 18;342:(8873):732
 
HSL9310
 Faivelson S.
 Merck Medco merger 
 Med World News 1993 Sep 15;34:30-31
 
HSL20518
 Follea L
 Drug companies under fire for their Third World advertising practices
 Le Monde 1993 Sep 1513
 
HSL5164
 Lexchin J.
 Physicians and drug companies interact.
 Can Fam Physician 1993 Sep 01;39:1881-2
 
HSL5698
 Borow W.
 The AMA explains its about-face on direct-to-consumer advertising
 Medical Marketing & Media 1993 Sep 01;28:(9):68-69, 72, 74
 
HSL5695
 Organon claims Tolvon has “similar levels of efficacy as amitripyline, imipramine and clomipramine, but is associated with significantly less side-effects” and is “similar in efficacy and side-effects to the newer anti-depressants with which it has been compared”
 MaLAM Australian News 1993 Sep
 
HSL5696
 Re: the promotion of Kaopectato/Kaopectate (kaolin with pectin)
 1993 Sep
 
HSL5697
 Re: the promotion of Tolvon (mianserin)
 1993 Sep
 
HSL9311
 Laskoski G.
 Generics: too good for their own good 
 Am Drug 1993 Sep;208:30-32, 34-35
 
HSL5242
 Mossinghoff GJ.
 Drug labelling in developing countries.
 
Lancet 1993 Aug 28;342:(8870):556-7
 
HSL5018
 Kassirer JP, Angell M.
 Financial conflicts of interest in biomedical research.
 
N Engl J Med 1993 Aug 19;329:(8):570-1
 
HSL5517
 Thompson DF.
 Understanding financial conflicts of interest.
 N Engl J Med 1993 Aug 19;329:(8):573-6
 
http://content.nejm.org/cgi/content/extract/329/8/573
HSL4694
 Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont
 Development of residency program guidelines for interaction with the pharmaceutical industry.
  CMAJ 1993 Aug 15;149:(4):405-08
 
HSL5529
 Woollard RF.
 Addressing the pharmaceutical industry's influence on professional behaviour.
 
CMAJ 1993 Aug 15;149:(4):403-4
 
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=8348421
HSL5527
 Williams JR.
 General Council to consider amendments to CMA policy on MDs' relationships with drug industry.
 
CMAJ 1993 Aug 1;149:(3):335-7
 
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=11659649
HSL5691
 Re: the promotion of Augmentin (amoxycillin/clavulinic acid)
 1993 Aug
 
HSL5692
 SmithKline Beecham claims “when you need to be sure in otitis media and sinusitis, you need Augmentin”
 MaLAM Australian News 1993 Aug
 
http://jcp.sagepub.com/cgi/reprint/40/10/1102
HSL5693
 Bala K.
 Towards ethical prescribing information
 HAI News 1993 Aug
 
HSL9333
 Vosper HJ, Frewen TC.
 Physician education and prescribing costs.
 
Pharmacoeconomics 1993 Aug;4:(2):77-84
 
HSL5167
 Mann J, Crooke M, Fear H, Hay D, Jackson R, Neutze J, White H.
 Pharmaceutical company sponsorship.
 
N Z Med J 1993 Jul 28;106:(960):318
 
HSL9329
 Rankin K.
 New Medicare catastrophic Rx plan . . . but can pharmacy live with it? 
 Drug Store News for Pharm 1993 Jul 26;3:23
 
HSL4681
 Levine SJ, Barton TL.
 Labels for nonprescription medications.
 N Engl J Med 1993 Jul 22;329:(4):280-1
 
HSL9321
 Conlan MF.
 Rx outpatient benefit for Medicare under review again 
 Drug Top 1993 Jul 19;137:39
 
HSL20163
 Liebman H
 Consumer, heal thyself; ads for prescription drugs are popping up more frequently in consumer media.
 Mediaweek 1993 July 5
 
http://business.highbeam.com/137332/article-1G1-14018400/consumer-heal-thyself-ads-prescription-drugs-popping
HSL5689
 Physicians say direct-to-consumer advertising affects patient behavior.
  Am J Hosp Pharm 1993 Jul 01;50:(7):1329
 
HSL4659
 Physicians say direct-to-consumer advertising affects patient behavior.
 Am J Hosp Pharm 1993 Jul;50:(7):1329
 
HSL5240
 Mitchell AB.
 Doctors, drug companies and free lunches: a clinical tutor's view.
 
J R Coll Physicians Lond 1993 Jul;27:(3):313-4
 
HSL5518
 Uzych L.
 Direct-to-the-consumer advertising of drug products.
 
Pa Med 1993 Jul;96:(7):16-7
 
HSL5688
 Rhone-Poulenc Rorer claims Denoral is “new” and “unique”, “protects nasal mucosa” and “overcomes cough”
 MaLAM International News 1993 Jul
 
HSL9313
 Arnold RB.
 Self-regulation of the promotion and marketing of prescription medicines 
 Drugs Made Ger 1993 Jul-Sep;36:75-78
 
HSL9315
 Just a spoonful of sugar... 
 NARD J 1993 Jul;115:86
 
HSL9331
 Report of pre-approval inspection program for drugs-FDA answers your questions 
 Pharm Eng 1993 Jul-Aug;13:48-54
 
HSL9370
 Physicians say direct-to-consumer advertising affects patient behavior.
 Am J Hosp Pharm. 1993 Jul;50:(7):1329
 
HSL5244
 O'Mahony B.
 Interactions between a general practitioner and representatives of drug companies.
 
BMJ 1993 Jun 19;306:(6893):1649
 
HSL5172
 Merikangas JR.
 Changing over-the-counter drugs while retaining the brand name.
 
Ann Intern Med 1993 Jun 15;118:(12):988
 
http://www.annals.org/cgi/content/full/118/12/988
HSL5516
 Suresh CG, Greene D, Coupe MO.
 Use of adenosine and effectiveness of pharmaceutical marketing.
 
Lancet 1993 Jun 12;341:(8859):1539-40
 
HSL5253
 Rothman KJ.
 Conflict of interest. The new McCarthyism in science
 JAMA 1993 Jun 02;269:2782-2784
 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8192721&dopt=Abstract
HSL4666
 Andrews G.
 Promoting non-drug therapies.
 Aust N Z J Psychiatry 1993 Jun 01;27:(2):341-2
 
HSL5168
 Marley J, Mant A.
 Post marketing surveillance. Traps for the unwary.
 Aust Fam Physician 1993 Jun 01;22:(6):1009-11,
 
HSL5515
 Sullivan P.
 CMA launches major campaign to support new MDs' right to practise.
 
CMAJ 1993 Jun 1;148:(11):1998-2000
 
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=8500037
HSL4682
 Chirac P, Pikon A, Poinsignon Y, Vitry A.
 Drug marketing in French-speaking African countries.
 
Soc Sci Med 1993 Jun;36:(12):1541-3
 
HSL4690
 Dixon T.
 Pharmaceutical advertising Information or influence?
 Can Fam Physician 1993 Jun;39:1298-300,
 
HSL4704
 Hogan DJ, Sarel D, Canas A, Bellman B, Eaglstein W, Hogan LA, Kramer J.
 An analysis of advertisements in the Journal of the American Academy of Dermatology, 1980 and 1990.
 
J Am Acad Dermatol 1993 Jun;28:(6):993-7
 
HSL5680
 MaLAM:  the industry watchdog
 HAI News 1993 Jun
 
HSL5681
 Re: the promotion of Polymagma and Entox-P (attapulgite)
 1993 Jun
 
HSL5682
 Re: the promotion of Toradol (ketorolac)
 1993 Jun
 
HSL5683
 Syntex claims Toradol has “narcotic efficacy without narcotic drawbacks”
 MaLAM Australian News 1993 Jun
 
HSL5684
 Frankel J.
 Selling to doctors in Europe
 Scrip Magazine 1993 Jun26-29
 
HSL5685
 Janssen claims “adverse reactions are unlikely”
 MaLAM Australian News 1993 Jun
 
HSL5686
 Re: the promotion of Denoral (buzepide/clocinizine/pholcodine)
 1993 Jun
 
HSL5687
 Re: the promotion of Nizoral (oral ketoconazole)
 1993 Jun
 
HSL9324
 Bashe G, Murray L.
 Mail order pharmacy puts Rx companies in the middle 
 Med Mark Media 1993 Jun;28:20-22, 24, 26
 
HSL5523
 Weaving PG.
 Drug company representatives and sales priorities.
 
Lancet 1993 May 29;341:(8857):1416
 
HSL4668
 Ariano RE, Zelenitsky SA.
 Ketorolac (Toradol): a marketing phenomenon.
 CMAJ 1993 May 15;148:(10):1686-8
 
HSL5257
 Spickler W.
 Ketorolac (Toradol): a new analgesic or an old NSAID?
 
CMAJ 1993 May 15;148:(10):1693-5
 
HSL5022
 Klein M.
 Novel gifts from pharmaceutical companies.
 
N Engl J Med 1993 May 13;328:(19):1426
 
HSL5549
 Editorial
 Health Horizons 1993 May
 
HSL5677
 Re: the promotion of Periactin (cyproheptadine)
 1993 May
 
HSL5678
 Summary of outcomes for topics commenced November 1991 to January 1992
 MaLAM International Newsletter 1993 May
 
HSL5679
 Critser G.
 Dealing a new antidepressant:  little pills get a big push onto the market
 Harper’s 1993 May54-55
 
HSL9317
 Clark G.
 Ethical rule changed again 
 S Afr Pharm J 1993 May;60:146
 
HSL9328
 Ostrowidzki V.
 Drugmakers fire back 
 Am Drug 1993 May;207:7-8, 9
 
HSL5012
 Humphreys DM.
 Unpublished data in drug advertisements.
 
BMJ 1993 Apr 24;306:(6885):1127
 
HSL5169
 Massam D.
 Unpublished data in drug advertisements.
 
BMJ 1993 Apr 24;306:(6885):1127
 
HSL4667
 Angel JE.
 Publication of sponsored symposiums in medical journals.
 
N Engl J Med 1993 Apr 22;328:(16):1196
 
HSL4696
 Finucane TE.
 Publication of sponsored symposiums in medical journals.
 N Engl J Med 1993 Apr 22;328:(16):1197
 
HSL5017
 Kasper CK.
 Publication of sponsored symposiums in medical journals.
 
N Engl J Med 1993 Apr 22;328:(16):1197
 
HSL5170
 Massie BM, Rothenberg D.
 Publication of sponsored symposiums in medical journals.
 
N Engl J Med 1993 Apr 22;328:(16):1196-7
 
HSL5252
 Roberts MS.
 Publication of sponsored symposiums in medical journals.
 
N Engl J Med 1993 Apr 22;328:(16):1197
 
HSL9326
 Ukens C.
 Multitier prices will be dead issue, pharmacists told 
 Drug Top 1993 Apr 19;137:88
 
Page 180 of 206 pages ‹ First < 178 179 180 181 182 > Last ›
 








 


